PAA 2.33% 21.0¢ pharmaust limited

Clinical Trials Interview June 2022, page-16

  1. 129 Posts.
    lightbulb Created with Sketch. 39
    Great balanced discussion on PAA threads at the moment
    my top 3 positives to come out of recent announcements
    Pilot FDA trial for dogs in America. The best thing is that the vets over there managing the trial have a great self interest in the outcome, I think they will be keen to drive it along at a good pace

    MND trial (very exciting) I believe FightMND have a great network/ connections to people suffering from MND
    This will ensure the best possible watchdog style pressure on PAA management to keep on task

    Our two new recruits at Epichem
    Our new manager would have had a choice of places to work with her resume
    She obviously sees great potential in our award winning Epichem

    Cheers
    Bunyip
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
-0.005(2.33%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 21.0¢ $85.73K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 53482 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 278844 4
View Market Depth
Last trade - 15.15pm 19/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.